Wei‐Chung Cheng

iLipidome analyzes lipidomics data using biosynthetic networks to improve statistical power and interpretability, identifying genetic causes of lipid changes and potential therapeutic targets.

This study uses nanopore sequencing to identify structural variants in breast cancer with high specificity and sensitivity, revealing repetitive DNA as a major source of variation.